Company Overview
- Headquarters
- 6565 W. Loop South, Suite 400, Bellaire TX
- Website
- sightlinehealth.com
- Phone
- (713) 589-6879
- Employees
- 27
- Founded in
- 2005
- Industry
- Medical Equipment
Financials & Stats
Revenue
$50B
Who is SightLine Health
SightLine Health is a medical device company based in Bellaire, Texas, dedicated to providing patients with innovative, non-invasive treatment options. With 27 employees and generating $50 million in revenue, SightLine is a leader in bringing cutting-edge medical technology to the forefront of patient care. The company focuses on developing and offering incision-free treatments for a range of conditions, including uterine fibroids in women and intensity-modulated radiation therapy for prostate cancer in men. SightLine's commitment to staying at the forefront of medical innovation is evident in their continuous assessment of emerging technologies and their partnerships with leading medical experts. SightLine's unique approach involves collaborating with top physicians to identify and evaluate promising technologies, often before they become widely available. This allows them to offer patients access to the latest medical breakthroughs in a convenient and comfortable setting. Their state-of-the-art facilities are designed to provide a positive and supportive experience for patients undergoing these advanced treatments. For more information about SightLine Health and their innovative treatment options, visit their website at sightlinehealth.com.
Company Leadership
SightLine Health Industry Tags
Companies Similar to SightLine Health
Analyze industry trends and opportunities by examining competitors and companies comparable to SightLine Health, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
50M | 138 | |||
50M | 102 | Princeton, NJ | ||
50M | 221 | New Prague, MN | 1992 | |
50M | 229 | Malvern, PA | ||
50M | 181 | Malvern, PA | 2012 |